Carl Atkinson, PhD.PULMONOLOGY SCIENTIFIC ADVISORY BOARD
Associate Professor of Microbiology and Immunology, Medical University of South Carolina, USA
Carl Atkinson is an Associate Professor of Microbiology and Immunology at the Medical University of South Carolina, USA. Dr. Atkinson obtained his first bachelors’ degree in Biomedical Science at Kingston University, UK in 1993 and his second from the University of the West of England, UK in 1998 in cellular pathology. He completed his doctoral studies in 2004, also at the University of the West on England, UK, in the field of transplant immunology. During his PhD studies Dr. Atkinson was Chief Biomedical Scientist in the Department of Pathology at Papworth Hospital NHS Trust, UK. Upon completion of his doctoral studies Dr. Atkinson relocated to Medical University of South Carolina, USA to work with the eminent complement biology researcher Dr. Stephen Tomlinson. In 2006 Dr. Atkinson moved onto faculty at the Medical University of South Carolina and was appointed Associate Professor in 2012.
Dr. Atkinson is a co-founder and CSO of ToleRaM NanoTech, LLC. He is an expert in the area of complement biology, complement therapeutics, transplantation biology and respiratory disease.
Dr. Atkinson’s research interests revolve around complement biology, with a focus on understanding the mechanistic interplay between the complement system and the adaptive immune response. These studies encompass a wide array of disease types, which include; emphysema, asthma, sinusitis, heart, lung, liver and kidney transplantation, and age related macular degeneration. Central to these studies is understanding the complement pathophysiology associated with these diseases to enable the design, construction and therapeutic testing of novel complement inhibitory strategies for therapeutic translation.